No­var­tis' San­doz reshuf­fles an­tibi­ot­ic sup­ply chain in EU as field faces a short­age of in­vest­ment

While much of the fo­cus in man­u­fac­tur­ing has shift­ed away from an­tibi­otics, a di­vi­sion of No­var­tis is putting mon­ey in­to a Eu­ro­pean ex­pan­sion. San­doz will …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER